文献速递眼底病与葡萄膜炎

通过单细胞转录组分析鉴定Hif1α为自身免疫性葡萄膜炎发病的潜在参与者

Identification of Hif1α as a Potential Participant in Autoimmune Uveitis Pathogenesis Using Single-Cell Transcriptome Analysis.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2023-01-01

本研究旨在描绘自身免疫性葡萄膜炎(AU)发病相关的转录变化并鉴定潜在治疗靶点。在实验性AU(EAU)模型中,对颈部引流淋巴结细胞进行单细胞RNA测序,发现缺氧诱导因子1α(Hif1α)可能通过调节Th17、Th1和调节性T细胞参与EAU发病;抑制Hif1α可减轻EAU症状,且抑制Hif1α表达的CD4+ T细胞无法过继转移EAU。在Vogt-Koyanagi-Harada病中,CD4+ T细胞中Hif1α也升高并调节其增殖。

要点

  • 单细胞RNA测序提示Hif1α可能通过调节Th17、Th1和调节性T细胞参与EAU发病。
  • 抑制Hif1α可减轻EAU症状并调节Th17、Th1和调节性T细胞比例。
  • 抑制Hif1α表达的CD4+ T细胞未能将EAU过继转移给naïve小鼠。

核心结论

  • 结果表明Hif1α可能参与AU发病,因此是潜在的治疗靶点。

研究设计与样本

  • 建立用视网膜抗原和佐剂诱导的实验性AU(EAU)模型,并以仅用佐剂建立EAU对照组以排除非特异性效应。
  • 对EAU组、EAU对照组和正常小鼠的颈部引流淋巴结细胞进行单细胞RNA测序(scRNA-seq)。
  • 后续进行流式细胞术、过继转移实验、人葡萄膜炎scRNA-seq分析和增殖评估以验证目标分子在葡萄膜炎中的功能。

主要发现

  • scRNA-seq数据提示缺氧诱导因子1α(Hif1α)可能通过调节Th17、Th1和调节性T细胞参与EAU发病。
  • 抑制Hif1α减轻EAU症状并调节Th17、Th1和调节性T细胞比例。
  • 抑制Hif1α表达的CD4+ T细胞未能将EAU过继转移给naïve小鼠。
  • 在Vogt-Koyanagi-Harada病中,CD4+ T细胞中Hif1α也升高并调节其增殖。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This study purposed to depict the transcriptional changes associated with autoimmune uveitis (AU) pathogenesis and identify potential therapeutic targets of this disease. METHODS: An experimental AU (EAU) model was established with retina antigen and adjuvants. An EAU control group was established with adjuvant only to eliminate nonspecific effects. We conducted single-cell RNA sequencing (scRNA-seq) on cervical draining lymph node cells of EAU, EAU control, and normal mice to identify the EAU-associated transcriptional changes and the potential pathogenic molecules. Subsequent flow cytometry, adoptive transfer experiment, scRNA-seq analysis of human uveitis, and proliferation assessment were conducted to verify the function of the interested molecule in uveitis. RESULTS: The scRNA-seq data suggested that hypoxia-inducible factor 1 alpha (Hif1α) may participate in EAU pathogenesis via regulating T helper (Th)-17, Th1, and regulatory T cells. Hif1α inhibition alleviated EAU symptoms and regulated Th17, Th1, and regulatory T cell proportions. CD4+ T cells with repressed Hif1α expression failed to transfer EAU to naïve mice. In Vogt-Koyanagi-Harada disease, which is a human uveitis, Hif1α was also increased in CD4+ T cells and regulated their proliferation. CONCLUSIONS: The results indicate that Hif1α may participate in AU pathogenesis and are, thus, a potential therapeutic target.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Zhu L, Li H, Wang R, et al. Identification of Hif1α as a Potential Participant in Autoimmune Uveitis Pathogenesis Using Single-Cell Transcriptome Analysis. Invest Ophthalmol Vis Sci. 2023. PMID: 37227746. doi:10.1167/iovs.64.5.24

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。